This includes building effective processes to collect, transport, test samples and return the results to patients for timely clinical interventions
Roche through its Global Access Program, and The Global Fund to fight AIDS, tuberculosis and malaria are joining forces to build and strengthen diagnostic capacity and pandemic preparedness in low-and middle-income countries fighting against HIV and tuberculosis (TB). The partnership aims to improve the diagnosis of HIV and TB in LMICs by building local capacity to tackle fundamental infrastructure challenges for generating and delivering diagnostic results and managing healthcare waste.
This includes building effective processes to collect, transport, test samples and return the results to patients for timely clinical interventions, as well as addressing challenges arising from a lack of network infrastructure, workforce capacity, access to roads, and IT systems. The partnership will also include novel approaches to reduce the environmental and economic burden of healthcare waste generated during the testing process itself and the disposal of instruments and medical devices at the end of its/their useful life.
Thomas Schinecker, CEO, Roche Diagnostics said, “Roche is excited to join forces with the Global Fund and their partners to support countries in developing critical diagnostic networks in the global fight against HIV and TB. Connecting our experts with critical local stakeholders, we are aiming to help build sustainable solutions that could be scaled across countries.”
Peter Sands, Executive Director, Global Fund said, “Getting people to test for HIV and TB is fundamental to containing transmission and enrolling people on treatment, which are crucial steps to saving lives and ending these diseases as public health threats. We are pleased to partner with Roche in expanding access to diagnostics tools for HIV and TB. These efforts will strengthen the fight against these diseases and help the world prepare better for future pandemics.”
Through collaboration with the Global Fund, Ministries of Health and country-based partners, Roche will first support assessments and implementation of new technologies and knowledge transfer in 2 to 3 pilot countries, with the ambition to scale up and expand support in 10 countries over the next five years.